In a cell model of Alzheimer’s disease, the effects of ICT on decreasing the levels of GSK-3β and phosphorylated Tau have been found to be slightly better than that of ICA [19]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.